A Study to Investigate the Safety and Efficacy of Once-weekly PEG-somatropin (GenSci004) in Children With Growth Hormone Deficiency
Clinical trial NCT06024967 · UNKNOWN
Trial details
- NCT number
- NCT06024967
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-01
- Primary completion
- 2025-05-01
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.